Literature DB >> 11939908

Multiple regions within the promoter of the murine Ifnar-2 gene confer basal and inducible expression.

Matthew P Hardy1, Paul J Hertzog, Catherine M Owczarek.   

Abstract

The (murine) type I interferon (IFN) receptor, muIfnar-2, is expressed ubiquitously, and exists as both transmembrane and soluble forms. In the present study we show that the gene encoding muIfnar-2 spans approx. 33 kb on mouse chromosome 16, and consists of nine exons and eight introns. The three mRNA splice variants resulting in one transmembrane (muIfnar-2c) and two soluble (muIfnar-2a/2a') mRNA isoforms are generated by alternative RNA processing of the muIfnar-2 gene. Treatment of a range of murine cell lines with a combination of type I and II IFN showed that the muIfnar-2a and -2c mRNA isoforms were up-regulated independently of each other in L929 fibroblasts and hepa-1c1c7 hepatoma cells, but not in M1 myeloid leukaemia cells. Analysis of the 5' flanking region of muIfnar-2 using promoter-luciferase reporter constructs defined three regulatory regions: a region proximal to exon 1, conferring high basal expression, a distal region conferring inducible expression, and a negative regulatory region between the two. These data represent the first promoter analysis of a type I IFN receptor and, taken together with our previous data demonstrating high expression levels and dual biological functions for muIfnar-2a protein, suggests that the regulation of muIfnar-2 isoform expression may be an important way of modulating type I IFN responses.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11939908      PMCID: PMC1222688          DOI: 10.1042/BJ20020105

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  55 in total

Review 1.  The type I interferon receptor: structure, function, and evolution of a family business.

Authors:  K E Mogensen; M Lewerenz; J Reboul; G Lutfalla; G Uzé
Journal:  J Interferon Cytokine Res       Date:  1999-10       Impact factor: 2.607

Review 2.  Role of the cytoplasmic domains of the type I interferon receptor subunits in signaling.

Authors:  C Prejean; O R Colamonici
Journal:  Semin Cancer Biol       Date:  2000-04       Impact factor: 15.707

3.  Structure of the 5'-flanking region of the rat prostaglandin F(2alpha) receptor gene and its transcriptional control functions in hepatocytes.

Authors:  F Neuschäfer-Rube; U Möller; G P Püschel
Journal:  Biochem Biophys Res Commun       Date:  2000-11-19       Impact factor: 3.575

4.  Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL.

Authors:  T Heinemeyer; E Wingender; I Reuter; H Hermjakob; A E Kel; O V Kel; E V Ignatieva; E A Ananko; O A Podkolodnaya; F A Kolpakov; N L Podkolodny; N A Kolchanov
Journal:  Nucleic Acids Res       Date:  1998-01-01       Impact factor: 16.971

5.  The soluble murine type I interferon receptor Ifnar-2 is present in serum, is independently regulated, and has both agonistic and antagonistic properties.

Authors:  M P Hardy; C M Owczarek; S Trajanovska; X Liu; I Kola; P J Hertzog
Journal:  Blood       Date:  2001-01-15       Impact factor: 22.113

6.  Comparative genome sequence analysis of the Bpa/Str region in mouse and Man.

Authors:  A M Mallon; M Platzer; R Bate; G Gloeckner; M R Botcherby; G Nordsiek; M A Strivens; P Kioschis; A Dangel; D Cunningham; R N Straw; P Weston; M Gilbert; S Fernando; K Goodall; G Hunter; J S Greystrong; D Clarke; C Kimberley; M Goerdes; K Blechschmidt; A Rump; B Hinzmann; C R Mundy; W Miller; A Poustka; G E Herman; M Rhodes; P Denny; A Rosenthal; S D Brown
Journal:  Genome Res       Date:  2000-06       Impact factor: 9.043

7.  The human CC chemokine receptor 5 (CCR5) gene. Multiple transcripts with 5'-end heterogeneity, dual promoter usage, and evidence for polymorphisms within the regulatory regions and noncoding exons.

Authors:  S Mummidi; S S Ahuja; B L McDaniel; S K Ahuja
Journal:  J Biol Chem       Date:  1997-12-05       Impact factor: 5.157

8.  Active conservation of noncoding sequences revealed by three-way species comparisons.

Authors:  I Dubchak; M Brudno; G G Loots; L Pachter; C Mayor; E M Rubin; K A Frazer
Journal:  Genome Res       Date:  2000-09       Impact factor: 9.043

9.  Identification of a coordinate regulator of interleukins 4, 13, and 5 by cross-species sequence comparisons.

Authors:  G G Loots; R M Locksley; C M Blankespoor; Z E Wang; W Miller; E M Rubin; K A Frazer
Journal:  Science       Date:  2000-04-07       Impact factor: 47.728

10.  Fine structure of the murine leptin receptor gene: splice site suppression is required to form two alternatively spliced transcripts.

Authors:  S C Chua; I K Koutras; L Han; S M Liu; J Kay; S J Young; W K Chung; R L Leibel
Journal:  Genomics       Date:  1997-10-15       Impact factor: 5.736

View more
  5 in total

1.  A default pathway of memory CD8 T cell differentiation after dendritic cell immunization is deflected by encounter with inflammatory cytokines during antigen-driven proliferation.

Authors:  Nhat-Long L Pham; Vladimir P Badovinac; John T Harty
Journal:  J Immunol       Date:  2009-07-27       Impact factor: 5.422

2.  Inflammation activates the interferon signaling pathways in taste bud cells.

Authors:  Hong Wang; Minliang Zhou; Joseph Brand; Liquan Huang
Journal:  J Neurosci       Date:  2007-10-03       Impact factor: 6.167

3.  Transcriptional regulation of the human TRIF (TIR domain-containing adaptor protein inducing interferon beta) gene.

Authors:  Matthew P Hardy; Anne F McGGettrick; Luke A J O'Neill
Journal:  Biochem J       Date:  2004-05-15       Impact factor: 3.857

Review 4.  Antiviral RNAi in Insects and Mammals: Parallels and Differences.

Authors:  Susan Schuster; Pascal Miesen; Ronald P van Rij
Journal:  Viruses       Date:  2019-05-16       Impact factor: 5.048

5.  Soluble Receptor Isoform of IFN-Beta (sIFNAR2) in Multiple Sclerosis Patients and Their Association With the Clinical Response to IFN-Beta Treatment.

Authors:  Pablo Aliaga-Gaspar; Isaac Hurtado-Guerrero; Nicolas Lundahl Ciano-Petersen; Patricia Urbaneja; Isabel Brichette-Mieg; Virginia Reyes; Jose Luis Rodriguez-Bada; Roberto Alvarez-Lafuente; Rafael Arroyo; Ester Quintana; Lluis Ramió-Torrentà; Ana Alonso; Laura Leyva; Oscar Fernández; Begoña Oliver-Martos
Journal:  Front Immunol       Date:  2021-12-16       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.